Chas Pulido

Chas Pulido is the Founder and General Partner at Alix Ventures, which focuses on supporting early-stage Life Science startups aimed at advancing human health. Chas also serves as a Creator at BIOS, emphasizing unity in the Life Science ecosystem. As an investor, Chas has contributed to various companies including Mythic Therapeutics, Inc., Strand Therapeutics, ELEGEN, Zafrens, Genyro Inc., IORGANBIO, Chemify Limited, and LYRIC BIO, often collaborating with notable co-investors. Chas's educational background includes participation in Y Combinator and studies at the University of Notre Dame - Mendoza College of Business, along with early education at The Bishop's School.